CURIONIC BIOTHERAPEUTICS
Curionic Biotherapeutics develops a platform technology designed to discover protein therapeutics. It allows for the controlled release of protein therapeutics to specific tissues over time. Curionic Biotherapeutics' technology has been proven effective for post-heart attack recovery, with additional indications for wound healing, chemotherapeutics, and neurodegenerative diseases.
CURIONIC BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Status:
Active
Similar Organizations
Biolexis Therapeutics
Biolexis Therapeutics is a cutting-edge FIELDS technology to design potent and selective small molecule therapeutics.
Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals develops new imaging agents for use in diagnosis and management of disease, and to help other companies.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
More informations about "Curionic Biotherapeutics"
Curionic Biotherapeutics - PitchBook
Curionic Biotherapeutics General Information Description. Developer of platform technology intended to discover protein therapeutics. The company develops bio-pharmaceutical proteins …See details»
Curionic Biotherapeutics | Pittsburgh, PA, USA Startup
Curionic Biotherapeutics Controlled delivery of bioactive therapeutics for post-heart attack cardiac repair. Stage Product In Development Industry Biotechnology Location Pittsburgh, PA, USA …See details»
Curionic Biotherapeutics - Idea Foundry
Curionic Biotherapeutics. Platform technology which allows for controlled release of protein therapeutics to specific tissues over time. Website. It has been proven effective for post heart …See details»
Curionic Biotherapeutics - Crunchbase
Curionic Biotherapeutics develops a platform technology designed to discover protein therapeutics.See details»
Integrative Enzymatics - Crunchbase
Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals.See details»
Curi Bio, Genetox, and DreamCIS Sign MOU for Strategic …
SEATTLE, February 22, 2024--Curi Bio announced the signing of a MOU for collaboration with Genetox and DreamCIS for advancing BOTAONE through US FDA approval.See details»
101 Best Pennsylvania Health Care Companies and Startups
Dec 30, 2021 This article showcases our top picks for the best Pennsylvania based Health Care companies. These startups and companies are taking a variety of approaches to innovating …See details»
CuriRx launches Advanced Bioprocessing and Analytical Center
Jan 27, 2022 CuriRx is a contract development and manufacturing organization that offers upstream and downstream process development, optimization, characterization, scale-up and …See details»
Curie.Bio – Swiss Biotech
Curie.Bio is a new model for venture capital in biotech focused on helping founders launch serious therapeutics companies. We've combined two businesses in our model: we act as both your …See details»
Pop Therapeutics - Crunchbase
Pop has developed a platform technology that aids in the discovery of novel therapeutic compounds.See details»
Curionic
In 1981, Ronald Reagan fired 11,345 air traffic controllers after they refused to end their strike and subsequently banned them from federal service for lifeSee details»
CurioLab
FLEXIBLE. Programmed to analyse endpoint, fixed time and kinetic assays; Storage for 200 user programmable test methods and 10000 test results; Create up to 10 customised test profilesSee details»
Biomanufacturing partnership boosts Canada’s life-saving …
Sep 13, 2021 The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) is the most experienced and successful facility of its kind in Canada, having manufactured more than a …See details»
Protalix BioTherapeutics Issues 2025 Letter to Stockholders
13 hours ago Protalix BioTherapeutics Issues 2025 Letter to Stockholders Protalix BioTherapeutics Issues 2025 Letter to Stockholders. PR Newswire. CARMIEL, Israel, Dec. 23, …See details»
Protalix BioTherapeutics Issues 2025 Letter to Stockholders
1 hour ago CARMIEL, Israel, Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company focused on the development, …See details»
GTC Biotherapeutics - Crunchbase Company Profile & Funding
GTC Biotherapeutics is located in Framingham, Massachusetts, United States. Who are GTC Biotherapeutics 's competitors? Alternatives and possible competitors to GTC Biotherapeutics …See details»
From Conception to Manufacturing. Accelerating Therapies with …
In this podcast, we will explore the advantages of partnering with a Contract Development and Manufacturing Organization (CDMO) to navigate the journey from molecule conception to …See details»
Nutent Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Nutent Therapeutics may include ARKAY Therapeutics, Selexagen Therapeutics, and Curionic Biotherapeutics. Unlock even more features with …See details»
Protalix BioTherapeutics Issues 2025 Letter to Stockholders - PR …
1 hour ago CARMIEL, Israel, Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company focused on the development, …See details»
Pop Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Pop Therapeutics may include Curionic Biotherapeutics. Unlock even more features with Crunchbase Pro Start Your Free TrialSee details»